A 35-year-old man with HIV infection (CD4 count 150 cells/μL) presents with extensive, rapidly progressive warts on his hands, feet, and genitalia. The lesions are hyperkeratotic, verrucous, and some show signs of malignant transformation with irregular borders and bleeding. Biopsy of a genital lesion shows koilocytosis and mild dysplasia. Which HPV type is most likely to be found in this patient, and what is the primary concern?

Explanation

## Clinical Context: Immunosuppressed Host with Aggressive Warts The patient has severe immunosuppression (CD4 <200 cells/μL) with: - Extensive, rapidly progressive warts - Multi-site involvement (hands, feet, genitalia) - Signs of malignant transformation (irregular borders, bleeding) - Histologic dysplasia on biopsy ## HPV Types in Immunocompromised Patients | HPV Type | Risk Category | Clinical Behavior in AIDS | Malignant Potential | |----------|---------------|--------------------------|--------------------| | HPV-1, 2, 4 | Low-risk | Benign, self-limited | None | | HPV-6, 11 | Low-risk | Aggressive genital warts | Rare | | HPV-16, 18, 31, 33 | High-risk | Rapid progression, dysplasia | High (SCC, cervical, anal cancer) | **Key Point:** HPV-16 is the most common high-risk type found in immunocompromised patients with aggressive warts and dysplastic changes. It is strongly associated with squamous cell carcinoma (SCC) of the anogenital region, cervical cancer, and anal cancer. **High-Yield:** In HIV-positive patients with CD4 <200 cells/μL, HPV-16 causes rapidly progressive, dysplastic warts with high malignant potential. The risk of anal and cervical cancer is significantly elevated compared to immunocompetent individuals. **Clinical Pearl:** Koilocytosis (perinuclear halos around nuclei) on histology is the hallmark of HPV infection and indicates active viral replication. The presence of dysplasia in a koilocytic lesion suggests high-risk HPV type involvement. ## Pathophysiology in Immunosuppression ```mermaid flowchart TD A[CD4 < 200 cells/μL]:::urgent --> B[Loss of T-cell immunity] B --> C[Impaired HPV clearance] C --> D[Persistent high-risk HPV infection] D --> E[Viral replication and dysplasia] E --> F[Malignant transformation] F --> G[SCC of anogenital region]:::outcome G --> H[Cervical/anal cancer risk]:::urgent ``` **Mnemonic:** **HIGH-RISK HPV in AIDS** = HPV-16/18/31/33 → **H**igh malignant potential, **I**mmunosuppression accelerates progression, **G**enital/anal SCC, **H**ealth monitoring essential.